Clinical trial
Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blood Cell Properties (AI-ACS Trial)
NCT06384846 is registered in ClinicalTrials.gov with RobotDreams GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blood Cell Properties (AI-ACS Trial)
- Lead sponsor
- RobotDreams GmbH
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 3,350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, angina pectoris, nstemi - non-st segment elevation mi, stemi - st elevation myocardial infarction, unstable angina (ua)